{"gene":"PRPSAP1","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":1994,"finding":"PRPSAP1 (PAP39), a 39-kDa protein, was cloned from rat liver and found to physically interact with PRPP synthetase catalytic subunits (PRS I and PRS II) via covalent cross-linking and immunoprecipitation experiments. Removal of PAP39 from the native complex (by gel filtration with MgCl2 or mild trypsin treatment) increased catalytic activity, demonstrating a negative regulatory role for PAP39 on PRPP synthetase activity.","method":"cDNA cloning, covalent cross-linking, immunoprecipitation, enzymatic activity assays after PAP39 depletion","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (cross-linking, Co-IP, activity assay) in a single rigorous study","pmids":["8132556"],"is_preprint":false},{"year":1995,"finding":"PAP39 (PRPSAP1) is a component of the high-molecular-weight rat liver PRPP synthetase complex composed of PRS I, PRS II, PAP39, and a 41-kDa protein. PAP39 shows ~48% amino acid identity with the catalytic subunits, lacks catalytic activity, and inhibits PRPP synthesis. Its mRNA is expressed in a tissue-differential manner, indicating that complex composition and hence enzyme properties vary by tissue.","method":"cDNA cloning, Northern blot, biochemical fractionation, activity assays","journal":"Advances in enzyme regulation","confidence":"High","confidence_rationale":"Tier 2 — corroborates and extends findings from multiple labs with biochemical and molecular evidence","pmids":["7572345"],"is_preprint":false},{"year":1997,"finding":"Recombinant PAP39 (PRPSAP1) expressed as a GST fusion protein in E. coli bound equally to dissociated PRS I and PRS II catalytic subunits. Co-expression of PAP39 with PRS I or PRS II in E. coli reconstituted soluble complexes of variable composition; higher relative PAP39 content lowered specific catalytic activity in an amount-dependent manner, providing strong evidence that PAP39 has no catalytic activity but exerts inhibitory effects proportional to its abundance in the complex.","method":"Recombinant protein expression, GST pulldown, in situ reconstitution in E. coli, enzymatic activity assays","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1 — partial reconstitution in E. coli with quantitative activity measurements and binding assays","pmids":["9366267"],"is_preprint":false},{"year":1998,"finding":"Kinetic analysis of the native rat liver PRPP synthetase complex (containing PRS I, PRS II, PAP39, and PAP41) showed weaker nucleotide inhibition sensitivity than expected from the composition of its catalytic subunits alone. High free Mg2+ concentrations nullified inhibition by MgGDP almost completely and partly that by MgADP on PRS I, with the native liver enzyme (including PAP39-containing complex) showing an intermediate response, indicating that PAPs modulate the regulatory properties of the enzyme complex.","method":"Kinetic enzymatic assays under controlled free Mg2+ and nucleotide concentrations","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 1 — rigorous kinetic assays, but role of PAP39 specifically is inferred from complex composition rather than isolated PAP39 manipulation","pmids":["9748490"],"is_preprint":false},{"year":1996,"finding":"The promoter region of the rat PAP39 (PRPSAP1) gene is GC-rich and contains putative binding sites for regulatory transcription factors. Transfection of a promoter-CAT reporter construct into rat PC12 cells demonstrated promoter activity, establishing the regulatory region of the PRPSAP1 gene.","method":"Gene isolation, sequencing, CAT reporter transfection assay","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 — direct functional demonstration of promoter activity in cells","pmids":["8611622"],"is_preprint":false},{"year":2014,"finding":"In U87 glioma cells, hypoxia suppressed PRPSAP1 and PRPSAP2 gene expression only when ERN1 (endoplasmic reticulum stress kinase/endoribonuclease) was knocked down, whereas PRPS1 and PRPS2 were suppressed by hypoxia regardless of ERN1 status. This indicates that ERN1-mediated ER stress signaling modulates PRPSAP1 expression under hypoxic conditions, placing PRPSAP1 downstream of the ERN1 pathway.","method":"ERN1 knockdown in glioma cells, real-time RT-PCR under hypoxia and ER stress conditions","journal":"Ukrainian biochemical journal","confidence":"Low","confidence_rationale":"Tier 3 — single lab, expression-level readout, no direct mechanistic dissection","pmids":["25816608"],"is_preprint":false},{"year":2024,"finding":"Using isogenic fibroblast clones in combinatorial PRPS complex assembly states, PRPSAP1 was shown to be required for proper oligomeric assembly of the PRPP synthetase complex: cells lacking PRPS2, PRPSAP1, and PRPSAP2 drove PRPS1 into aberrant homo-oligomeric assemblies with diminished metabolic flux and impaired proliferative capacity. PRPSAP1 was defined as preferentially interacting with specific subunits, and translational control mechanisms were identified as enabling fine-tuned regulation of PRPS complex assembly and activity.","method":"Isogenic fibroblast KO clones, native complex analysis, metabolic flux assays, proliferation assays","journal":"bioRxiv","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (genetic knockout series, metabolomics, proliferation), systematic combinatorial approach","pmids":["39411161"],"is_preprint":true},{"year":2025,"finding":"Using a rapid degron system in multiple human cell lines, depletion of PRPSAP1 was shown to limit histone availability and disrupt chromatin assembly independently of its role in nucleotide biosynthesis, revealing a previously unrecognized function of PRPSAP1 in early histone maturation and coordinating nucleotide metabolism with chromatin formation.","method":"Rapid protein degradation (degron) system, histone availability assays, chromatin assembly assays in multiple cell lines","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 — acute depletion with orthogonal functional readouts (histone maturation, chromatin assembly) across multiple cell lines","pmids":["41344329"],"is_preprint":false},{"year":2022,"finding":"Fructose treatment increased the gene expression, protein expression, and fluorescence intensity of PRPSAP1 in mouse livers via increased mTOR expression, placing PRPSAP1 regulation downstream of the mTOR pathway in the context of fructose-induced purine de novo synthesis and hyperuricemia.","method":"RNA-seq, immunofluorescence, Western blotting in hepatic cells and mouse livers with fructose treatment","journal":"Frontiers in nutrition","confidence":"Low","confidence_rationale":"Tier 3 — expression and localization data, mechanistic link to mTOR inferred without direct perturbation of PRPSAP1 function","pmids":["36601078"],"is_preprint":false}],"current_model":"PRPSAP1 (PAP39) is a non-catalytic regulatory subunit of the mammalian PRPP synthetase complex that physically interacts with the catalytic subunits PRS I and PRS II to inhibit PRPP synthesis in an amount-dependent manner, shapes the oligomeric assembly and metabolic flux of the complex, and additionally plays a nucleotide biosynthesis-independent role in early histone maturation and chromatin assembly."},"narrative":{"teleology":[{"year":1994,"claim":"Identification of PAP39 as a physically associated, non-catalytic inhibitory component of PRPP synthetase resolved how the native enzyme complex is negatively regulated beyond allosteric nucleotide feedback.","evidence":"cDNA cloning, covalent cross-linking, co-immunoprecipitation, and enzymatic activity assays after PAP39 depletion from rat liver complex","pmids":["8132556"],"confidence":"High","gaps":["Stoichiometry of PAP39 within the native complex not determined","Whether PAP39 alters substrate affinity vs. Vmax not resolved","No structural information on how PAP39 contacts catalytic subunits"]},{"year":1997,"claim":"Reconstitution of PRPS–PAP39 complexes in E. coli established that PAP39 binds PRS I and PRS II equally and exerts dose-dependent inhibition, answering whether its regulatory effect is stoichiometric rather than allosteric.","evidence":"Recombinant GST-PAP39 pulldown and co-expression reconstitution in E. coli with quantitative activity measurements","pmids":["9366267"],"confidence":"High","gaps":["Whether PAP39 competes with PAP41 for the same binding site on catalytic subunits","No mammalian cell reconstitution performed","Structural basis of inhibition unknown"]},{"year":1998,"claim":"Kinetic analysis of the native complex revealed that the presence of associated proteins including PAP39 modulates nucleotide inhibition sensitivity of PRPP synthetase, extending PAP39's role from simple activity suppression to shaping the enzyme's allosteric regulation.","evidence":"Kinetic enzymatic assays with controlled free Mg²⁺ and nucleotide inhibitor concentrations on native rat liver complex","pmids":["9748490"],"confidence":"Medium","gaps":["PAP39-specific contribution was inferred from complex composition rather than isolated manipulation","Whether PAP39 vs. PAP41 differentially influences nucleotide inhibition not dissected","No mutagenesis of PAP39 residues involved in allosteric modulation"]},{"year":2024,"claim":"Systematic genetic dissection using combinatorial knockout fibroblast clones demonstrated that PRPSAP1 is required for proper oligomeric assembly of the PRPS complex, with its loss leading to aberrant homo-oligomers, reduced metabolic flux, and impaired proliferation.","evidence":"Isogenic fibroblast KO clones with native complex analysis, metabolic flux assays, and proliferation assays (preprint)","pmids":["39411161"],"confidence":"High","gaps":["Preprint; not yet peer-reviewed","Relative contributions of PRPSAP1 vs. PRPSAP2 to assembly not fully delineated","Structural basis for how PRPSAP1 prevents aberrant oligomerization unknown"]},{"year":2025,"claim":"Acute degradation of PRPSAP1 revealed a nucleotide-biosynthesis-independent function in histone maturation and chromatin assembly, fundamentally expanding its role beyond metabolic regulation.","evidence":"Rapid degron-mediated depletion in multiple human cell lines with histone availability and chromatin assembly readouts","pmids":["41344329"],"confidence":"High","gaps":["Molecular mechanism linking PRPSAP1 to histone maturation not defined","Whether this function requires interaction with PRPS catalytic subunits or occurs independently is unclear","No structural or interactome data for the chromatin-related role"]},{"year":null,"claim":"The molecular mechanism by which PRPSAP1 promotes histone maturation independently of nucleotide biosynthesis, and the structural basis for its inhibitory and assembly roles within the PRPS complex, remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No atomic-resolution structure of PRPSAP1 or PRPSAP1-containing complex","Specific protein partners mediating the chromatin assembly function not identified","In vivo physiological consequences of PRPSAP1 loss in animal models not reported"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,2,3]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,1,2]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,1,2,3,6]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[7]}],"complexes":["PRPP synthetase complex"],"partners":["PRPS1","PRPS2","PRPSAP2"],"other_free_text":[]},"mechanistic_narrative":"PRPSAP1 (PAP39) is a non-catalytic regulatory subunit of the mammalian PRPP synthetase complex that inhibits phosphoribosyl pyrophosphate synthesis in proportion to its stoichiometric abundance within the complex [PMID:8132556, PMID:9366267]. It physically associates with the catalytic subunits PRPS1 and PRPS2 with equal affinity and is required for proper oligomeric assembly of the complex; its absence drives catalytic subunits into aberrant homo-oligomeric states with diminished metabolic flux and impaired cell proliferation [PMID:9366267, PMID:39411161]. Beyond nucleotide metabolism, PRPSAP1 functions in early histone maturation and chromatin assembly independently of its role in PRPP synthesis, coordinating nucleotide supply with chromatin formation [PMID:41344329]."},"prefetch_data":{"uniprot":{"accession":"Q14558","full_name":"Phosphoribosyl pyrophosphate synthase-associated protein 1","aliases":["39 kDa phosphoribosypyrophosphate synthase-associated protein","PAP39"],"length_aa":356,"mass_kda":39.4,"function":"Seems to play a negative regulatory role in 5-phosphoribose 1-diphosphate synthesis","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/Q14558/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PRPSAP1","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"PARP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/PRPSAP1","total_profiled":1310},"omim":[{"mim_id":"601249","title":"PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE-ASSOCIATED PROTEIN 1; PRPSAP1","url":"https://www.omim.org/entry/601249"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PRPSAP1"},"hgnc":{"alias_symbol":["PAP39"],"prev_symbol":[]},"alphafold":{"accession":"Q14558","domains":[{"cath_id":"3.40.50.2020","chopping":"7-151","consensus_level":"high","plddt":94.307,"start":7,"end":151},{"cath_id":"3.40.50.2020","chopping":"153-200_241-326","consensus_level":"high","plddt":94.5223,"start":153,"end":326}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14558","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q14558-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q14558-F1-predicted_aligned_error_v6.png","plddt_mean":88.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PRPSAP1","jax_strain_url":"https://www.jax.org/strain/search?query=PRPSAP1"},"sequence":{"accession":"Q14558","fasta_url":"https://rest.uniprot.org/uniprotkb/Q14558.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q14558/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14558"}},"corpus_meta":[{"pmid":"7572345","id":"PMC_7572345","title":"Mammalian phosphoribosyl-pyrophosphate synthetase.","date":"1995","source":"Advances in enzyme regulation","url":"https://pubmed.ncbi.nlm.nih.gov/7572345","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14576983","id":"PMC_14576983","title":"Identification of differentially expressed genes in skeletal muscle of non-diabetic insulin-resistant and insulin-sensitive Pima Indians by differential display PCR.","date":"2003","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/14576983","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36601078","id":"PMC_36601078","title":"Dietary intake of fructose increases purine de novo synthesis: A crucial mechanism for hyperuricemia.","date":"2022","source":"Frontiers in nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/36601078","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8132556","id":"PMC_8132556","title":"A novel 39-kDa phosphoribosylpyrophosphate synthetase-associated protein of rat liver. Cloning, high sequence similarity to the catalytic subunits, and a negative regulatory role.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8132556","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31469419","id":"PMC_31469419","title":"Identification of novel epithelial ovarian cancer loci in women of African ancestry.","date":"2019","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31469419","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9545573","id":"PMC_9545573","title":"Molecular cloning of a human cDNA for the 41-kDa phosphoribosylpyrophosphate synthetase-associated protein.","date":"1998","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9545573","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9003449","id":"PMC_9003449","title":"Cloning and sequencing of rat cDNA for the 41-kDa phosphoribosylpyrophosphate synthetase-associated protein has a high homology to the catalytic subunits and the 39-kDa associated protein.","date":"1997","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9003449","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9748490","id":"PMC_9748490","title":"Rat liver phosphoribosylpyrophosphate synthetase is activated by free Mg2+ in a manner that overcomes its inhibition by nucleotides.","date":"1998","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9748490","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21594610","id":"PMC_21594610","title":"Hyperuricemia cosegregating with osteogenesis imperfecta is associated with a mutation in GPATCH8.","date":"2011","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21594610","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25816608","id":"PMC_25816608","title":"Expression of phosphoribosyl pyrophosphate synthetase genes in U87 glioma cells with ERN1 knockdown: effect of hypoxia and endoplasmic reticulum stress.","date":"2014","source":"Ukrainian biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/25816608","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9366267","id":"PMC_9366267","title":"Partial reconstitution of mammalian phosphoribosylpyrophosphate synthetase in Escherichia coli cells. Coexpression of catalytic subunits with the 39-kDa associated protein leads to formation of soluble multimeric complexes of various compositions.","date":"1997","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9366267","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31763365","id":"PMC_31763365","title":"Prostatic adenocarcinoma with novel NTRK3 gene fusion: a case report.","date":"2019","source":"American journal of clinical and experimental urology","url":"https://pubmed.ncbi.nlm.nih.gov/31763365","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39411161","id":"PMC_39411161","title":"Evolutionary origins and innovations sculpting the mammalian PRPS enzyme complex.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39411161","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8976111","id":"PMC_8976111","title":"[PRPP synthetase superactivity].","date":"1996","source":"Nihon rinsho. Japanese journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/8976111","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38972728","id":"PMC_38972728","title":"Exosomal mRNA in plasma serves as a predictive marker for microvascular invasion in hepatocellular carcinoma.","date":"2024","source":"Journal of gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/38972728","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18409517","id":"PMC_18409517","title":"[Increased activity of PRPP synthetase].","date":"2008","source":"Nihon rinsho. Japanese journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18409517","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41344329","id":"PMC_41344329","title":"Rate-limiting enzymes in nucleotide metabolism synchronize nucleotide biosynthesis and chromatin formation.","date":"2025","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/41344329","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38772598","id":"PMC_38772598","title":"NTRK3-Rearranged Prostatic Acinar Adenocarcinoma: Report of a Patient and Review of the Literature.","date":"2024","source":"International journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/38772598","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8611622","id":"PMC_8611622","title":"Promoter region of the rat phosphoribosylpyrophosphate synthetase-associated protein 39.","date":"1996","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/8611622","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3025681","id":"PMC_3025681","title":"[Cloning of DNA fragments of the genetic transfer factor pAP39].","date":"1986","source":"Molekuliarnaia genetika, mikrobiologiia i virusologiia","url":"https://pubmed.ncbi.nlm.nih.gov/3025681","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41566375","id":"PMC_41566375","title":"Comprehensive insights into sepsis-induced cardiac dysfunction through proteomics and metabolomics.","date":"2026","source":"BMC research notes","url":"https://pubmed.ncbi.nlm.nih.gov/41566375","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16189514","id":"PMC_16189514","title":"Towards a proteome-scale map of the human protein-protein interaction network.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16189514","citation_count":2090,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17353931","id":"PMC_17353931","title":"Large-scale mapping of human protein-protein interactions by mass spectrometry.","date":"2007","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/17353931","citation_count":733,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23263486","id":"PMC_23263486","title":"Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23263486","citation_count":657,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25910212","id":"PMC_25910212","title":"Widespread macromolecular interaction perturbations in human genetic disorders.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25910212","citation_count":454,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21145461","id":"PMC_21145461","title":"Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21145461","citation_count":318,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27342126","id":"PMC_27342126","title":"Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27342126","citation_count":306,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22863883","id":"PMC_22863883","title":"A high-throughput approach for measuring temporal changes in the interactome.","date":"2012","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/22863883","citation_count":273,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22678362","id":"PMC_22678362","title":"MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity.","date":"2012","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/22678362","citation_count":230,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17207965","id":"PMC_17207965","title":"hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes.","date":"2007","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17207965","citation_count":222,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21988832","id":"PMC_21988832","title":"Toward an understanding of the protein interaction network of the human liver.","date":"2011","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/21988832","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26673895","id":"PMC_26673895","title":"A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26673895","citation_count":198,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32807901","id":"PMC_32807901","title":"UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination.","date":"2020","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32807901","citation_count":168,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30833792","id":"PMC_30833792","title":"A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30833792","citation_count":159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"36217030","id":"PMC_36217030","title":"A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.","date":"2022","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36217030","citation_count":140,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34349018","id":"PMC_34349018","title":"Protein interaction landscapes revealed by advanced in vivo cross-linking-mass spectrometry.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34349018","citation_count":113,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11003,"output_tokens":1636,"usd":0.028775},"stage2":{"model":"claude-opus-4-6","input_tokens":4878,"output_tokens":1734,"usd":0.10161},"total_usd":0.283365,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":22107,"output_tokens":2285,"usd":0.050298},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":5826,"output_tokens":1573,"usd":0.102682}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"PAP39 (rat ortholog of PRPSAP1) physically interacts with the catalytic subunits PRS I and PRS II of PRPP synthetase, as shown by covalent cross-linking and immunoprecipitation. Removal of PAP39 from the native liver enzyme complex by gel filtration in high MgCl2 or mild tryptic treatment increased catalytic activity, establishing a negative regulatory role for PAP39 in PRPP synthesis.\",\n      \"method\": \"Covalent cross-linking, immunoprecipitation, gel filtration with enzymatic activity assay, mild tryptic treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal biochemical methods (cross-linking, Co-IP, activity reconstitution) in a single foundational study; replicated in subsequent reconstitution work\",\n      \"pmids\": [\"8132556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"PAP39 (PRPSAP1 ortholog) was partially reconstituted with PRS I and PRS II in E. coli by co-expression. PAP39 alone had no PRPP synthetase activity but bound both catalytic subunits with similar affinity. Increasing the relative amount of PAP39 lowered specific catalytic activities of the complex in an amount-dependent manner, confirming its inhibitory role within the complex.\",\n      \"method\": \"Recombinant co-expression in E. coli, GST-fusion pulldown, in vitro enzymatic activity assay, proteolysis assay\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis-level controls, confirming inhibitory mechanism established in PMID 8132556\",\n      \"pmids\": [\"9366267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"PAP39 (PRPSAP1) is a component of the large mammalian PRPP synthetase aggregate alongside PRS I, PRS II, and PAP41. The deduced amino acid sequence of PAP39 is highly similar to the catalytic subunits (48% identity to PRS I) yet lacks catalytic activity. The tissue-differential expression of PAP39 relative to PRS isoforms suggests that PRPP synthetase complex composition, and hence enzyme properties, vary by tissue.\",\n      \"method\": \"cDNA cloning, sequence analysis, Northern blot, recombinant expression in E. coli\",\n      \"journal\": \"Advances in enzyme regulation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — review summarizing original cloning and biochemical data; functional conclusions supported by primary papers\",\n      \"pmids\": [\"7572345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The native rat liver PRPP synthetase complex (containing PAP39/PRPSAP1 and PAP41 alongside PRS I and PRS II) showed weaker sensitivity to ADP and GDP inhibition than expected from the composition of the catalytic subunits alone. Kinetic studies under controlled free Mg2+ concentrations demonstrated that high free Mg2+ can overcome nucleotide inhibition of PRS I, and that the overall behavior of the native enzyme complex differs from the isolated catalytic subunits, implicating the associated proteins in modulating allosteric regulation.\",\n      \"method\": \"Kinetic enzymatic assays with controlled free Mg2+ concentrations, native liver enzyme vs. recombinant subunit comparison\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro kinetic assays comparing native complex (containing PRPSAP1) to isolated subunits; single study\",\n      \"pmids\": [\"9748490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Using isogenic fibroblast clones in all viable individual or combinatorial PRPS subunit assembly states, cells lacking PRPS2, PRPSAP1, and PRPSAP2 together rendered PRPS1 into aberrant homo-oligomeric assemblies with diminished metabolic flux and impaired proliferative capacity. PRPSAP1 and PRPSAP2 were shown to have preferential interactions with specific subunits and to be required for normal heteromeric complex assembly and function.\",\n      \"method\": \"Isogenic fibroblast clones with combinatorial KO, metabolic flux analysis, biochemical complex characterization, proliferation assay\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstitution of complex in multiple genetic backgrounds with metabolic flux and functional readouts; single preprint but multiple orthogonal methods\",\n      \"pmids\": [\"39411161\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Using a rapid degron system in multiple human cell lines, depletion of PRPSAP1 (independently of its role in nucleotide biosynthesis) limited histone availability and disrupted chromatin assembly, revealing a previously unrecognized role for PRPSAP1 in early histone maturation.\",\n      \"method\": \"Auxin-inducible degron system, multiple human cell lines, histone availability assay, chromatin assembly assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — rapid degron depletion with specific functional readouts (histone maturation, chromatin assembly) in multiple cell lines; peer-reviewed\",\n      \"pmids\": [\"41344329\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PRPSAP1 (PAP39) is a non-catalytic component of the large mammalian PRPP synthetase complex that physically interacts with the PRS I and PRS II catalytic subunits to negatively regulate PRPP synthesis and modulate allosteric inhibition by nucleotides; it is additionally required for proper heteromeric complex assembly (preventing aberrant PRPS1 homo-oligomerization), and, independent of nucleotide biosynthesis, plays a role in early histone maturation and chromatin assembly.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"PRPSAP1 (PAP39), a 39-kDa protein, was cloned from rat liver and found to physically interact with PRPP synthetase catalytic subunits (PRS I and PRS II) via covalent cross-linking and immunoprecipitation experiments. Removal of PAP39 from the native complex (by gel filtration with MgCl2 or mild trypsin treatment) increased catalytic activity, demonstrating a negative regulatory role for PAP39 on PRPP synthetase activity.\",\n      \"method\": \"cDNA cloning, covalent cross-linking, immunoprecipitation, enzymatic activity assays after PAP39 depletion\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (cross-linking, Co-IP, activity assay) in a single rigorous study\",\n      \"pmids\": [\"8132556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"PAP39 (PRPSAP1) is a component of the high-molecular-weight rat liver PRPP synthetase complex composed of PRS I, PRS II, PAP39, and a 41-kDa protein. PAP39 shows ~48% amino acid identity with the catalytic subunits, lacks catalytic activity, and inhibits PRPP synthesis. Its mRNA is expressed in a tissue-differential manner, indicating that complex composition and hence enzyme properties vary by tissue.\",\n      \"method\": \"cDNA cloning, Northern blot, biochemical fractionation, activity assays\",\n      \"journal\": \"Advances in enzyme regulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — corroborates and extends findings from multiple labs with biochemical and molecular evidence\",\n      \"pmids\": [\"7572345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Recombinant PAP39 (PRPSAP1) expressed as a GST fusion protein in E. coli bound equally to dissociated PRS I and PRS II catalytic subunits. Co-expression of PAP39 with PRS I or PRS II in E. coli reconstituted soluble complexes of variable composition; higher relative PAP39 content lowered specific catalytic activity in an amount-dependent manner, providing strong evidence that PAP39 has no catalytic activity but exerts inhibitory effects proportional to its abundance in the complex.\",\n      \"method\": \"Recombinant protein expression, GST pulldown, in situ reconstitution in E. coli, enzymatic activity assays\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — partial reconstitution in E. coli with quantitative activity measurements and binding assays\",\n      \"pmids\": [\"9366267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Kinetic analysis of the native rat liver PRPP synthetase complex (containing PRS I, PRS II, PAP39, and PAP41) showed weaker nucleotide inhibition sensitivity than expected from the composition of its catalytic subunits alone. High free Mg2+ concentrations nullified inhibition by MgGDP almost completely and partly that by MgADP on PRS I, with the native liver enzyme (including PAP39-containing complex) showing an intermediate response, indicating that PAPs modulate the regulatory properties of the enzyme complex.\",\n      \"method\": \"Kinetic enzymatic assays under controlled free Mg2+ and nucleotide concentrations\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — rigorous kinetic assays, but role of PAP39 specifically is inferred from complex composition rather than isolated PAP39 manipulation\",\n      \"pmids\": [\"9748490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The promoter region of the rat PAP39 (PRPSAP1) gene is GC-rich and contains putative binding sites for regulatory transcription factors. Transfection of a promoter-CAT reporter construct into rat PC12 cells demonstrated promoter activity, establishing the regulatory region of the PRPSAP1 gene.\",\n      \"method\": \"Gene isolation, sequencing, CAT reporter transfection assay\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional demonstration of promoter activity in cells\",\n      \"pmids\": [\"8611622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In U87 glioma cells, hypoxia suppressed PRPSAP1 and PRPSAP2 gene expression only when ERN1 (endoplasmic reticulum stress kinase/endoribonuclease) was knocked down, whereas PRPS1 and PRPS2 were suppressed by hypoxia regardless of ERN1 status. This indicates that ERN1-mediated ER stress signaling modulates PRPSAP1 expression under hypoxic conditions, placing PRPSAP1 downstream of the ERN1 pathway.\",\n      \"method\": \"ERN1 knockdown in glioma cells, real-time RT-PCR under hypoxia and ER stress conditions\",\n      \"journal\": \"Ukrainian biochemical journal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, expression-level readout, no direct mechanistic dissection\",\n      \"pmids\": [\"25816608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Using isogenic fibroblast clones in combinatorial PRPS complex assembly states, PRPSAP1 was shown to be required for proper oligomeric assembly of the PRPP synthetase complex: cells lacking PRPS2, PRPSAP1, and PRPSAP2 drove PRPS1 into aberrant homo-oligomeric assemblies with diminished metabolic flux and impaired proliferative capacity. PRPSAP1 was defined as preferentially interacting with specific subunits, and translational control mechanisms were identified as enabling fine-tuned regulation of PRPS complex assembly and activity.\",\n      \"method\": \"Isogenic fibroblast KO clones, native complex analysis, metabolic flux assays, proliferation assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (genetic knockout series, metabolomics, proliferation), systematic combinatorial approach\",\n      \"pmids\": [\"39411161\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Using a rapid degron system in multiple human cell lines, depletion of PRPSAP1 was shown to limit histone availability and disrupt chromatin assembly independently of its role in nucleotide biosynthesis, revealing a previously unrecognized function of PRPSAP1 in early histone maturation and coordinating nucleotide metabolism with chromatin formation.\",\n      \"method\": \"Rapid protein degradation (degron) system, histone availability assays, chromatin assembly assays in multiple cell lines\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — acute depletion with orthogonal functional readouts (histone maturation, chromatin assembly) across multiple cell lines\",\n      \"pmids\": [\"41344329\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Fructose treatment increased the gene expression, protein expression, and fluorescence intensity of PRPSAP1 in mouse livers via increased mTOR expression, placing PRPSAP1 regulation downstream of the mTOR pathway in the context of fructose-induced purine de novo synthesis and hyperuricemia.\",\n      \"method\": \"RNA-seq, immunofluorescence, Western blotting in hepatic cells and mouse livers with fructose treatment\",\n      \"journal\": \"Frontiers in nutrition\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — expression and localization data, mechanistic link to mTOR inferred without direct perturbation of PRPSAP1 function\",\n      \"pmids\": [\"36601078\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PRPSAP1 (PAP39) is a non-catalytic regulatory subunit of the mammalian PRPP synthetase complex that physically interacts with the catalytic subunits PRS I and PRS II to inhibit PRPP synthesis in an amount-dependent manner, shapes the oligomeric assembly and metabolic flux of the complex, and additionally plays a nucleotide biosynthesis-independent role in early histone maturation and chromatin assembly.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PRPSAP1 (PAP39) is a catalytically inactive, regulatory subunit of the mammalian PRPP synthetase complex that controls purine and pyrimidine nucleotide biosynthesis by restraining catalytic flux and shaping allosteric responses. It shares ~48% sequence identity with the catalytic subunit PRPS1 yet lacks enzymatic activity; instead, it physically associates with PRPS1 and PRPS2, and titration of PRPSAP1 into the complex dose-dependently suppresses PRPP synthetase activity, while the native complex containing PRPSAP1 displays altered sensitivity to ADP/GDP inhibition compared with isolated catalytic subunits [PMID:8132556, PMID:9366267, PMID:9748490]. PRPSAP1 is required for proper heteromeric assembly of the PRPP synthetase complex: in its combined absence with PRPSAP2 and PRPS2, PRPS1 forms aberrant homo-oligomers with diminished metabolic flux and impaired cell proliferation [PMID:39411161]. Independent of nucleotide biosynthesis, acute depletion of PRPSAP1 limits histone availability and disrupts chromatin assembly, establishing an additional role in early histone maturation [PMID:41344329].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing that PRPSAP1 is a physical component of the PRPP synthetase complex and a negative regulator of catalytic activity resolved the longstanding question of why the native mammalian enzyme behaved differently from purified catalytic subunits.\",\n      \"evidence\": \"Covalent cross-linking, co-immunoprecipitation, gel filtration with activity assays, and mild tryptic treatment on rat liver enzyme\",\n      \"pmids\": [\"8132556\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Stoichiometry of PRPSAP1 within the native complex not determined\",\n        \"Structural basis for the inhibitory interaction unknown\",\n        \"Whether PRPSAP1 regulation is conserved across species not tested\"\n      ]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Reconstitution of the complex from recombinant subunits demonstrated that PRPSAP1 inhibits catalysis in a dose-dependent manner and binds PRPS1 and PRPS2 with comparable affinity, confirming the inhibitory mechanism is intrinsic to PRPSAP1 rather than a co-purifying contaminant.\",\n      \"evidence\": \"Co-expression in E. coli, GST pulldown, in vitro activity assays with varying PRPSAP1 stoichiometry\",\n      \"pmids\": [\"9366267\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No structural data on binding interface\",\n        \"Whether PRPSAP1 and PRPSAP2 (PAP41) compete for the same binding site not resolved\"\n      ]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Kinetic comparison of the native PRPP synthetase complex with isolated catalytic subunits revealed that the associated proteins (including PRPSAP1) modulate allosteric inhibition by ADP and GDP, extending its regulatory role beyond simple activity suppression.\",\n      \"evidence\": \"Kinetic assays with controlled free Mg²⁺ on native rat liver complex versus recombinant subunits\",\n      \"pmids\": [\"9748490\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Individual contribution of PRPSAP1 versus PRPSAP2 to allosteric modulation not dissected\",\n        \"No mutational mapping of residues mediating allosteric effect\",\n        \"Single study without independent replication\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Combinatorial genetic deletion in human fibroblasts showed that PRPSAP1 and PRPSAP2 are essential for maintaining proper heteromeric complex architecture: without them, PRPS1 forms aberrant homo-oligomers with reduced metabolic flux and proliferative capacity, establishing a structural scaffolding role.\",\n      \"evidence\": \"(preprint) Isogenic fibroblast KO clones with metabolic flux analysis and biochemical complex characterization\",\n      \"pmids\": [\"39411161\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Preprint awaiting peer review\",\n        \"Relative contribution of PRPSAP1 alone (without PRPSAP2 loss) to assembly phenotype not fully isolated\",\n        \"Cryo-EM or high-resolution structure of the heteromeric complex not yet available\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Rapid degron-mediated depletion of PRPSAP1 uncovered a nucleotide-biosynthesis-independent function in histone maturation and chromatin assembly, fundamentally expanding its biological role beyond metabolic regulation.\",\n      \"evidence\": \"Auxin-inducible degron in multiple human cell lines with histone availability and chromatin assembly readouts\",\n      \"pmids\": [\"41344329\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular mechanism by which PRPSAP1 promotes histone maturation is unknown\",\n        \"Whether this chromatin function requires PRPSAP1 incorporation into the PRPP synthetase complex or operates as an independent moonlighting activity is unresolved\",\n        \"Relevant binding partners for the chromatin function not identified\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key outstanding questions include the structural basis of PRPSAP1's inhibitory and scaffolding roles within the PRPP synthetase complex, the molecular mechanism linking PRPSAP1 to histone maturation, and whether its metabolic and chromatin functions are coordinated or fully independent.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of PRPSAP1 in complex with PRPS subunits\",\n        \"Mechanism connecting PRPSAP1 to histone maturation pathway unknown\",\n        \"Physiological consequences of tissue-differential PRPSAP1 expression not characterized in vivo\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 3]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 3, 4]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"complexes\": [\"PRPP synthetase complex\"],\n    \"partners\": [\"PRPS1\", \"PRPS2\", \"PRPSAP2\"],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"PRPSAP1 (PAP39) is a non-catalytic regulatory subunit of the mammalian PRPP synthetase complex that inhibits phosphoribosyl pyrophosphate synthesis in proportion to its stoichiometric abundance within the complex [PMID:8132556, PMID:9366267]. It physically associates with the catalytic subunits PRPS1 and PRPS2 with equal affinity and is required for proper oligomeric assembly of the complex; its absence drives catalytic subunits into aberrant homo-oligomeric states with diminished metabolic flux and impaired cell proliferation [PMID:9366267, PMID:39411161]. Beyond nucleotide metabolism, PRPSAP1 functions in early histone maturation and chromatin assembly independently of its role in PRPP synthesis, coordinating nucleotide supply with chromatin formation [PMID:41344329].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Identification of PAP39 as a physically associated, non-catalytic inhibitory component of PRPP synthetase resolved how the native enzyme complex is negatively regulated beyond allosteric nucleotide feedback.\",\n      \"evidence\": \"cDNA cloning, covalent cross-linking, co-immunoprecipitation, and enzymatic activity assays after PAP39 depletion from rat liver complex\",\n      \"pmids\": [\"8132556\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of PAP39 within the native complex not determined\", \"Whether PAP39 alters substrate affinity vs. Vmax not resolved\", \"No structural information on how PAP39 contacts catalytic subunits\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Reconstitution of PRPS–PAP39 complexes in E. coli established that PAP39 binds PRS I and PRS II equally and exerts dose-dependent inhibition, answering whether its regulatory effect is stoichiometric rather than allosteric.\",\n      \"evidence\": \"Recombinant GST-PAP39 pulldown and co-expression reconstitution in E. coli with quantitative activity measurements\",\n      \"pmids\": [\"9366267\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PAP39 competes with PAP41 for the same binding site on catalytic subunits\", \"No mammalian cell reconstitution performed\", \"Structural basis of inhibition unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Kinetic analysis of the native complex revealed that the presence of associated proteins including PAP39 modulates nucleotide inhibition sensitivity of PRPP synthetase, extending PAP39's role from simple activity suppression to shaping the enzyme's allosteric regulation.\",\n      \"evidence\": \"Kinetic enzymatic assays with controlled free Mg²⁺ and nucleotide inhibitor concentrations on native rat liver complex\",\n      \"pmids\": [\"9748490\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"PAP39-specific contribution was inferred from complex composition rather than isolated manipulation\", \"Whether PAP39 vs. PAP41 differentially influences nucleotide inhibition not dissected\", \"No mutagenesis of PAP39 residues involved in allosteric modulation\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Systematic genetic dissection using combinatorial knockout fibroblast clones demonstrated that PRPSAP1 is required for proper oligomeric assembly of the PRPS complex, with its loss leading to aberrant homo-oligomers, reduced metabolic flux, and impaired proliferation.\",\n      \"evidence\": \"Isogenic fibroblast KO clones with native complex analysis, metabolic flux assays, and proliferation assays (preprint)\",\n      \"pmids\": [\"39411161\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Preprint; not yet peer-reviewed\", \"Relative contributions of PRPSAP1 vs. PRPSAP2 to assembly not fully delineated\", \"Structural basis for how PRPSAP1 prevents aberrant oligomerization unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Acute degradation of PRPSAP1 revealed a nucleotide-biosynthesis-independent function in histone maturation and chromatin assembly, fundamentally expanding its role beyond metabolic regulation.\",\n      \"evidence\": \"Rapid degron-mediated depletion in multiple human cell lines with histone availability and chromatin assembly readouts\",\n      \"pmids\": [\"41344329\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism linking PRPSAP1 to histone maturation not defined\", \"Whether this function requires interaction with PRPS catalytic subunits or occurs independently is unclear\", \"No structural or interactome data for the chromatin-related role\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular mechanism by which PRPSAP1 promotes histone maturation independently of nucleotide biosynthesis, and the structural basis for its inhibitory and assembly roles within the PRPS complex, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No atomic-resolution structure of PRPSAP1 or PRPSAP1-containing complex\", \"Specific protein partners mediating the chromatin assembly function not identified\", \"In vivo physiological consequences of PRPSAP1 loss in animal models not reported\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 2, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 2, 3, 6]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"complexes\": [\"PRPP synthetase complex\"],\n    \"partners\": [\"PRPS1\", \"PRPS2\", \"PRPSAP2\"],\n    \"other_free_text\": []\n  }\n}\n```"}